USCOM LIMITED — Regulatory Filings 2014

Sep 16, 2014

Uscom Limited ABN 35 091 028 090 Suite 1, Level 7, 10 Loftus Street Sydney NSW 2000 Australia T +612 9247 4144 F +612 9247 8157 www.uscom.com.au

==> picture [57 x 49] intentionally omitted <==

M A R K E T A N N O U N C E M E N T

Uscom Finalist in NSW Premier’s Export Awards

Sydney, Australia - 17 of September 2014: Uscom (ASX code: UCM) is pleased to announce it has been selected as a finalist in the NSW Premier’s Export Awards.

These annual Awards recognise excellence in the export of goods and services by NSW businesses and honours the state’s top exporters, raising their profile and bringing valuable business opportunities. The Awards recognise outstanding international success in the export of products, technology, equipment or services from NSW. NSW Trade & Investment is the principal sponsor of the 2014 Premier's NSW Export Awards in conjunction with the Export Council of Australia.

Lisa McAuley, COO of the Export Council of Australia said “ The Export Council of Australia congratulates Uscom Limited on being named a finalist in the 2014 Premier of NSW Export Awards and wishes them well at the awards ceremony on the 23rd October in Sydney .”

Executive Chairman of Uscom, Dr Rob Phillips said, “We are delighted to receive this recognition from the NSW Premier and The Export Council of Australia. Uscom is very focused on international markets and sells more than 95% of its products overseas. In the last year we have doubled our international distribution and written nearly $20m in distribution contracts. USCOM devices are being used in markets as diverse as Eastern Europe, South Africa, Russia, China, United Kingdom, the Middle East, USA and Mexico. We recently sold an Uscom 1A unit to a charity for use in the Paediatric ICU Department of the Timisoara Hospital in Romania. The commercialization of Australian technology and sales into global markets is vital for the health of the Australian economy, and we are proud to be a leader in that process.”

About the NSW Premier’s Export Awards

https://exportaward.com.au/nsw/newentry/intro.php

About Uscom

Uscom Limited is an ASX listed cardiovascular medical device company. Uscom is an innovative developer and manufacturer of premium cardiovascular devices and has two practice leading technologies in the field of cardiovascular monitoring, the USCOM 1A and the BP+. The devices are both clinically validated with FDA, CE and TGA regulatory approval, and are currently being marketed into global distribution networks.

The USCOM 1A is a simple, cost-effective and non-invasive device that measures heart function, detects abnormalities and guides treatment. The USCOM device has major applications in Paediatrics, Emergency, Intensive Care Medicine and Anesthesia, and is the device of choice for management of adult and paediatric sepsis, heart failure, and for the guidance of fluid therapy.

The Uscom BP+ is a supra systolic Central Blood Pressure monitor and replaces older and more widespread BP sub systolic Blood Pressure monitoring technology. Central Blood Pressure is becoming the new standard of care measurement in hypertension and heart failure. The Uscom BP+ provides a highly accurate and repeatable measurement of central and brachial blood pressure and pulse pressure waveforms using a familiar upper arm cuff. The BP+ is simple to use and requires no complex training with applications in hypertension, cardiology, intensive care, general practice and home care.

For more information, please visit: www.uscom.com.au ~~.~~

Uscom Contacts Rob Phillips Executive Chairman rob@uscom.com.au

Catherine Officer Company Secretary secretary@uscom.com.au